Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Effect of elexacaftor-texacaftor-ivacaftor in cystic fibrosis patients with advanced lung disease

Effect of elexacaftor-texacaftor-ivacaftor in cystic fibrosis patients with advanced lung disease

Resource Type

CF Research News

Authors

Bermingham, B.; Rueschhoff, A. Ratti, G. Nesmith, A., Goodwin D, Gray S, Flume P, Solomon, G. M., Cohen, L., Garcia, B.

References

J Cyst Fibros. 2021 Jun 21;S1569-1993(21)00160-0. doi: 10.1016/j.jcf.2021.05.009

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Date

Monday, June 21, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [3]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/effect-elexacaftor-texacaftor-ivacaftor-cystic-fibrosis-patients

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00575R2_FINAL_Garcia_140821.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34162524/ [3] https://www.ecfs.eu/resource-guideline-type/other-guidelines